Sandbox:Sahar
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recomendacations | Class | Level | References |
---|---|---|---|
History and clinical assessment | |||
In all patients with suspected
AAS, pre-test probability assessment is recommended, according to the patient’s condition, symptoms, and clinical features. |
|||
Laboratory testing | |||
In case of suspicion of AAS,
the interpretation of biomarkers should always be considered along with the pretest clinical probability. |
|||
In case of low clinical
probability of AAS, negative D-dimer levels should be considered as ruling out the diagnosis. |
|||
In case of intermediate clinical
probability of AAS with a positive (point-of-care) D-dimer test, further imaging tests should be considered. |
|||
In patients with high probability
(risk score 2 or 3) of AD, testing of D-dimers is not recommended. |
|||
Imaging | |||
TTE is recommended as an
initial imaging investigation. |
|||
In unstabled patients with a
suspicion of AAS, the following imaging modalities are recommended according to local availability and expertise: |
|||
TOE | |||
CT | |||
In stable patients with a
suspicion of AAS, the following imaging modalities are recommended (or should be considered) according to local availability and expertise: |
|||
CT | |||
MRI | |||
TOE |